Iconovo AB

Iconovo is a leading Swedish company in developing and commercializing advanced inhalation platforms and medicines. Listed on Nasdaq First North (ICO), it combines patented dry powder inhalers with pharmaceutical formulation expertise for end-to-end product development. Its devices include ICOres (multi-dose), ICOpre (single-dose) and ICOone Nasal. Works with generic and innovative pharma companies. Has received Gates Foundation support.